Neuragenex
Will Bozeman has extensive experience as a Chief Executive Officer and Founder in various biotechnology and regenerative medicine companies. Will served as the Chief Executive Officer at Neuragenex, Orthagenex, and Amnyo. Will also founded Regenerative Medical Technologies LLC (RegenMedTech) and Regenerative Medicine Providers. Additionally, they were the Chief Executive Officer at LAB BLOC, NovaGen Diagnostics, and Surgenex. Will also founded Magnacord Labs and Dexterity Health Inc. Will'sroles included overseeing product development, implementing clinical treatment protocols, and driving commercialization efforts.
Will Bozeman's education history includes:
- From 2013 to 2015, they attended the Alabama College of Osteopathic Medicine, studying Osteopathic Medicine/Osteopathy.
- From 2017 to 2019, they attended AT Still University of Health Sciences, where they earned a Doctor of Science degree in Healthcare and Regenerative Medicine.
- From 2010 to 2013, they attended Utah Valley University and obtained a Bachelor of Science degree in Biotechnology.
- From 2007 to 2009, they pursued a Master's degree at the University of Phoenix, with a focus on Business, Management, Marketing, and Related Support Services.
- From 2004 to 2007, they earned a Bachelor's degree from Brigham Young University, specializing in Classical, Ancient Mediterranean and Near Eastern Studies and Archaeology.
- From 2002 to 2004, they attended Shelton State Community College, earning an Associate of Science degree in Electrical and Electronics Engineering.
This person is not in any teams
Neuragenex
Neuragenex was founded as a next-generation chronic pain management program, offering a better way to manage chronic pain that not only relieves pain, but improves health and results in an enhanced and magnified quality of life. Neuragenex is a non-pharmaceutical, non-surgical, non-invasive, and non-chiropractic pain treatment program. As the nation’s fastest growing chronic pain treatment practice, our mission is to relieve pain, restore health, and magnify quality of life without drugs, surgery, or invasive procedures. Neuragenex has successfully treated thousands of chronic pain patients, many of which had no idea that an option like Neuragenex was available. Given the choice, patients will choose the least-invasive, most-effective, and longest-lasting treatment option available. This means that given the choice, patients will choose Neuragenex first over other conventional treatments like medications, surgeries, or invasive procedures and implants. Our vision is to be the first thought, first choice, and first step in the journey of chronic pain relief.